These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2883064)

  • 21. Vasoactive intestinal polypeptide response to ethanol in dogs.
    Misawa T; Aramaki J; Chijiiwa Y; Kabemura T; Nasu T; Nawata H
    Tohoku J Exp Med; 1990 May; 161(1):49-54. PubMed ID: 2396256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction.
    Gyöngyösi M; Kaszaki J; Németh J; Wolfárd A; Mojzes L; Farkas A
    Coron Artery Dis; 1997 Jun; 8(6):335-41. PubMed ID: 9347213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics.
    Fahrenkrug J; Ottesen B
    J Physiol; 1982 Oct; 331():451-60. PubMed ID: 7153911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
    Vergara P; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE
    J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enteric release of vasoactive intestinal peptide after a peptone meal in the dog.
    Wolfe MM; Misbin RI; Gardner DF; McGuigan JE
    Regul Pept; 1983 Jan; 5(2):103-9. PubMed ID: 6828775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of vasoactive intestinal polypeptide on gastric motility in the lamb.
    Reid AM; Shulkes A; Titchen DA
    J Physiol; 1988 Feb; 396():41-54. PubMed ID: 2900891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of motilin excitation of the canine small intestine.
    Fox JE; Daniel EE; Jury J; Robotham H
    Life Sci; 1984 Mar; 34(10):1001-6. PubMed ID: 6142392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.
    Fahrenkrug J; Galbo H; Holst JJ; Schaffalitzky de Muckadell OB
    J Physiol; 1978 Jul; 280():405-22. PubMed ID: 690895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase activating polypeptide stimulates gallbladder motility in conscious dogs.
    Mizumoto A; Fujimura M; Ohtawa M; Ueki S; Hayashi N; Itoh Z; Fujino M; Arimura A
    Regul Pept; 1992 Nov; 42(1-2):39-50. PubMed ID: 1362001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
    Eklund S; Jodal M; Lundgren O; Sjöqvist A
    Acta Physiol Scand; 1979 Apr; 105(4):461-8. PubMed ID: 452923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCl-stimulated duodenal HCO3- secretion in conscious rat. Interactions among VIP, nicotinic receptor mechanisms, and prostaglandins.
    Smedfors B; Theodorsson E; Johansson C
    Dig Dis Sci; 1994 Oct; 39(10):2134-42. PubMed ID: 7924732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension.
    Isaka M; Ueno H
    Open Vet J; 2021; 11(1):39-41. PubMed ID: 33898282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic atropine administration on regional vasoactive intestinal polypeptide concentrations in rat brain.
    Petit JM; Denoroy L; Jouvet M
    Eur J Pharmacol; 1992 Feb; 212(1):79-85. PubMed ID: 1555642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of atropine on plasma vasoactive intestinal polypeptide after intraduodenal infusion of fat in man.
    Lygren I; Jorde R; Burhol PG; Waldum HL
    Scand J Gastroenterol; 1982 Apr; 17(3):405-7. PubMed ID: 7134868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.
    Matsumura M; Saito S
    Endocrinol Jpn; 1989 Feb; 36(1):15-21. PubMed ID: 2731483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of insulin-induced hypoglycemia with and without atropine on plasma vasoactive intestinal polypeptide in man.
    Lygren I; Burhol PG; Jorde R; Waldum HL
    Scand J Gastroenterol; 1983 Jan; 18(1):155-9. PubMed ID: 6675173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relation of vasoactive intestinal peptide and acute hypoxia].
    Li X; Lu WC; Zhu YJ
    Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):8-10, 59. PubMed ID: 2401169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
    Nilsson SF; Bill A
    Acta Physiol Scand; 1984 Aug; 121(4):385-92. PubMed ID: 6148840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal polypeptide facilitates the late component of the 5-hydroxytryptamine-induced discharge in the cat superior cervical ganglion.
    Kawatani M; Rutigliano MJ; de Groat WC
    Neurosci Lett; 1987 Jan; 73(1):59-64. PubMed ID: 2882445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.